Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Sex Differences in the Impact of Obesity on Immunity

Vijayakumar S., Pantha S., Budha Magar S., Dhakal S.

Narrative Review on Autoimmune Research, published in Immunol Rev (2026) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Immunol Rev (2026)
Reported sample size
—
Source database
Europe PMC
PMID
41575180
PMCID
PMC12948493
DOI
10.1111/imr.70101
Citations
3

Abstract (original English)

The prevalence of obesity has increased significantly worldwide in the past few decades and is anticipated to rise further in the future. Obesity, characterized by excessive fat accumulation and chronic low-grade inflammation, dysregulates innate and adaptive immune responses, thereby increasing the risk of infectious diseases, cardiovascular diseases, and cancers. Males and females differ considerably in patterns of fat distribution, adipose tissue inflammation, and adipocytokine production, resulting in substantial sex-specific differences in metabolic health outcomes during obesity. Despite growing evidence of its importance, biological sex remains underprioritized in preclinical, clinical, and epidemiological obesity-related research. In this review, we explore the impact of biological sex on obesity-associated immune dysregulation and its consequences for a range of health outcomes, including infectious diseases, vaccine-induced immunity, autoimmune diseases, cancer, and cardiometabolic risk. We highlight recent findings from animal models and human studies to discuss the mechanistic roles of sex steroids and chromosome complements in shaping fat distribution, adipose inflammation, gut microbiota composition, and systemic inflammation, which collectively drive sex differences in obesity-associated immune responses. Greater consideration of biological sex in obesity researc

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsHumansObesityInflammationGonadal Steroid HormonesSex FactorsImmunitySex CharacteristicsFemale

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research